Atenção: Todas as denúncias são sigilosas e sua identidade será preservada.
Os campos nome e e-mail são de preenchimento opcional
Metadados | Descrição | Idioma |
---|---|---|
Autor(es): dc.contributor | mailto:lorenecoelho@hotmail.com | - |
Autor(es): dc.contributor | mailto:amabelfernandes@yahoo.com.br | - |
Autor(es): dc.contributor | mailto:dutra.joaovictor@gmail.com | - |
Autor(es): dc.contributor | mailto:wandersonromao@gmail.com | - |
Autor(es): dc.contributor | mailto:larissacmotta@gmail.com | - |
Autor(es): dc.contributor | mailto:acaciafagg@gmail.com | - |
Autor(es): dc.contributor | mailto:perolamagalhaes@unb.br | - |
Autor(es): dc.contributor | mailto:damaris@unb.br | - |
Autor(es): dc.contributor | mailto:yrisfonseca@unb.br | - |
Autor(es): dc.creator | Silva, Lorene Coelho | - |
Autor(es): dc.creator | Correia, Amabel Fernandes | - |
Autor(es): dc.creator | Gomes, João Victor Dutra | - |
Autor(es): dc.creator | Romão, Wanderson | - |
Autor(es): dc.creator | Motta, Larissa Campos | - |
Autor(es): dc.creator | Fagg, Christopher William | - |
Autor(es): dc.creator | Batista, Pérola de Oliveira Magalhães Dias | - |
Autor(es): dc.creator | Silveira, Dâmaris | - |
Autor(es): dc.creator | Fonseca-Bazzo, Yris Maria | - |
Data de aceite: dc.date.accessioned | 2024-07-24T13:15:25Z | - |
Data de disponibilização: dc.date.available | 2024-07-24T13:15:25Z | - |
Data de envio: dc.date.issued | 2022-08-02 | - |
Data de envio: dc.date.issued | 2022-08-02 | - |
Data de envio: dc.date.issued | 2022-05-06 | - |
Fonte completa do material: dc.identifier | https://repositorio.unb.br/handle/10482/44375 | - |
Fonte completa do material: dc.identifier | https://doi.org/10.3390/molecules27092976 | - |
Fonte: dc.identifier.uri | http://educapes.capes.gov.br/handle/capes/847339 | - |
Descrição: dc.description | Candida species are the main fungal agents causing infectious conditions in hospital patients. The development of new drugs with antifungal potential, increased efficacy, and reduced toxicity is essential to face the challenge of fungal resistance to standard treatments. The aim of this study is to evaluate the in vitro antifungal effects of two crude extracts of Crinum americanum L., a rich alkaloid fraction and lycorine alkaloid, on the Candida species. As such, we used a disk diffusion susceptibility test, determined the minimum inhibitory concentration (MIC), and characterized the components of the extracts using Electrospray Ionization Fourier Transform Ion Cyclotron Resonance Mass Spectrometry (ESI FT-ICR MS). The extracts were found to have antifungal activity against various Candida species. The chemical characterization of the extracts indicated the presence of alkaloids such as lycorine and crinine. The Amaryllidaceae family has a promising antifungal potential. Furthermore, it was found that the alkaloid lycorine directly contributes to the effects that were observed for the extracts and fraction of C. americanum. | - |
Formato: dc.format | application/pdf | - |
Publicador: dc.publisher | MDPI | - |
Direitos: dc.rights | Acesso Aberto | - |
Direitos: dc.rights | Molecules - No special permission is required to reuse all or part of article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. Reuse of an article does not imply endorsement by the authors or MDPI. Fonte: https://www.mdpi.com/openaccess. Acesso em: 02 ago. 2022. | - |
Palavras-chave: dc.subject | Antifúngicos | - |
Palavras-chave: dc.subject | Licorina | - |
Palavras-chave: dc.subject | Crino americano | - |
Palavras-chave: dc.subject | Candida | - |
Título: dc.title | Lycorine alkaloid and Crinum americanum L. (Amaryllidaceae) extracts display antifungal activity on clinically relevant candida species | - |
Tipo de arquivo: dc.type | Artigo | - |
Aparece nas coleções: | Repositório Institucional – UNB (old) |
O Portal eduCAPES é oferecido ao usuário, condicionado à aceitação dos termos, condições e avisos contidos aqui e sem modificações. A CAPES poderá modificar o conteúdo ou formato deste site ou acabar com a sua operação ou suas ferramentas a seu critério único e sem aviso prévio. Ao acessar este portal, você, usuário pessoa física ou jurídica, se declara compreender e aceitar as condições aqui estabelecidas, da seguinte forma: